These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26895468)

  • 1. Does an NKT-cell-based immunotherapeutic approach have a future in multiple myeloma?
    Favreau M; Vanderkerken K; Elewaut D; Venken K; Menu E
    Oncotarget; 2016 Apr; 7(17):23128-40. PubMed ID: 26895468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Harnessing natural killer T (NKT) cells in human myeloma: progress and challenges.
    Dhodapkar MV; Richter J
    Clin Immunol; 2011 Aug; 140(2):160-6. PubMed ID: 21233022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting Natural Killer T Cells in Solid Malignancies.
    Ingram Z; Madan S; Merchant J; Carter Z; Gordon Z; Carey G; Webb TJ
    Cells; 2021 May; 10(6):. PubMed ID: 34072042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunotherapeutic strategies targeting natural killer T cell responses in cancer.
    Shissler SC; Bollino DR; Tiper IV; Bates JP; Derakhshandeh R; Webb TJ
    Immunogenetics; 2016 Aug; 68(8):623-38. PubMed ID: 27393665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Natural Killer T Cells in Cancer-A Phenotypical and Functional Approach.
    Krijgsman D; Hokland M; Kuppen PJK
    Front Immunol; 2018; 9():367. PubMed ID: 29535734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harnessing CD1d-restricted T cells toward antitumor immunity in humans.
    Neparidze N; Dhodapkar MV
    Ann N Y Acad Sci; 2009 Sep; 1174():61-7. PubMed ID: 19769737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type II Natural Killer T Cells Contribute to Protection Against Systemic Methicillin-Resistant
    Genardi S; Visvabharathy L; Cao L; Morgun E; Cui Y; Qi C; Chen YH; Gapin L; Berdyshev E; Wang CR
    Front Immunol; 2020; 11():610010. PubMed ID: 33312179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor cells loaded with α-galactosylceramide promote therapeutic NKT-dependent anti-tumor immunity in multiple myeloma.
    Hong S; Lee H; Jung K; Lee SM; Lee SJ; Jun HJ; Kim Y; Song H; Bogen B; Choi I
    Immunol Lett; 2013; 156(1-2):132-9. PubMed ID: 24148970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Navigating the Role of CD1d/Invariant Natural Killer T-cell/Glycolipid Immune Axis in Multiple Myeloma Evolution: Therapeutic Implications.
    Papoutselis M; Spanoudakis E
    Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):358-365. PubMed ID: 32234294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response.
    Liu W; Huber SA
    Virol J; 2011 Jan; 8():32. PubMed ID: 21255407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of NKT cells in tumor immunity.
    Terabe M; Berzofsky JA
    Adv Cancer Res; 2008; 101():277-348. PubMed ID: 19055947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Invariant NKT cells as novel targets for immunotherapy in solid tumors.
    Pilones KA; Aryankalayil J; Demaria S
    Clin Dev Immunol; 2012; 2012():720803. PubMed ID: 23118781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Natural Killer T (NKT) Cells in Myeloma Biology and Therapy.
    Dhodapkar MV
    Crit Rev Oncog; 2024; 29(1):63-68. PubMed ID: 38421714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Adaptor Proteins in the Biology of Natural Killer T (NKT) Cells.
    Gerth E; Mattner J
    Front Immunol; 2019; 10():1449. PubMed ID: 31293596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyzing Antigen Recognition by Natural Killer T Cells.
    Zeissig S; Blumberg RS
    Methods Mol Biol; 2019; 1988():439-453. PubMed ID: 31147957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo induction and expansion of natural killer T cells by CD1d1-Ig coated artificial antigen presenting cells.
    Webb TJ; Bieler JG; Schneck JP; Oelke M
    J Immunol Methods; 2009 Jul; 346(1-2):38-44. PubMed ID: 19446558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-regulation between distinct natural killer T cell subsets influences immune response to self and foreign antigens.
    Arrenberg P; Halder R; Kumar V
    J Cell Physiol; 2009 Feb; 218(2):246-50. PubMed ID: 18814145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis of NKT cell inhibition using the T-cell receptor-blocking anti-CD1d antibody 1B1.
    Ying G; Wang J; Mallevaey T; Van Calenbergh S; Zajonc DM
    J Biol Chem; 2019 Aug; 294(35):12947-12956. PubMed ID: 31296659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Type II NKT Cells: An Elusive Population With Immunoregulatory Properties.
    Singh AK; Tripathi P; Cardell SL
    Front Immunol; 2018; 9():1969. PubMed ID: 30210505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-Specific Roles of NKT Cells in Tumor Immunity.
    Terabe M; Berzofsky JA
    Front Immunol; 2018; 9():1838. PubMed ID: 30158927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.